Authors:
FALCHERO L
COIFFIER B
GUIBERT B
SOUQUET PJ
PINET SI
TRILLETLENOIR V
Citation: L. Falchero et al., MALIGNANT PLEURAL MESOTHELIOMA FOLLOWING RADIOTHERAPY FOR HODGKINS-DISEASE, Bulletin du cancer, 83(11), 1996, pp. 964-968
Authors:
SALLES G
BIENVENU J
BASTION Y
BARBIER Y
DOCHE C
WARZOCHA K
GUTOWSKI MC
RIEUX C
COIFFIER B
Citation: G. Salles et al., ELEVATED CIRCULATING LEVELS OF TNF-ALPHA AND ITS P55 SOLUBLE RECEPTORARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTS, British Journal of Haematology, 93(2), 1996, pp. 352-359
Authors:
HIDDEMANN W
LONGO DL
COIFFIER B
FISHER RI
CABANILLAS F
CAVALLI F
NADLER LM
DEVITA VT
LISTER TA
ARMITAGE JO
Citation: W. Hiddemann et al., LYMPHOMA CLASSIFICATION - THE GAP BETWEEN BIOLOGY AND CLINICAL MANAGEMENT IS CLOSING, Blood, 88(11), 1996, pp. 4085-4089
Authors:
ROCHANT H
FENAUX P
GUERCI A
COIFFIER B
DREYFUS F
BELANGER C
ELONEN E
KANGASAHO M
JOUHIKAINEN T
Citation: H. Rochant et al., RESULTS OF HEME ARGINATE TREATMENT OF MYELODYSPLASTIC SYNDROMES - A MULTICENTER PHASE-II STUDY OF THE FRENCH GROUP OF MYELODYSPLASTIC SYNDROMES, Blood, 88(10), 1996, pp. 3566-3566
Authors:
GISSELBRECHT C
LEPAGE E
MOREL P
LEDERLIN P
COIFFIER B
TILLY H
BOSLY A
GABARRE J
BRIERE J
FILLET G
MOLINA T
REVES F
Citation: C. Gisselbrecht et al., INTENSIFIED INDUCTION-PHASE INCLUDING AUTOLOGOUS PERIPHERAL STEM-CELLTRANSPLANTATION DOES NOT IMPROVE RESPONSE RATE AND SURVIVAL IN LYMPHOMA WITH AT LEAST 2 ADVERSE PROGNOSTIC FACTORS WHEN COMPARED TO ACVB REGIMEN, Blood, 88(10), 1996, pp. 470-470
Authors:
THIEBLEMONT C
BERGER F
BASTION Y
SALLES G
DUMONTET C
RIEUX C
FELMAN P
COIFFIER B
Citation: C. Thieblemont et al., MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) GASTROINTESTINAL AND NONGASTROINTESTINAL LYMPHOMA - COMPARISON OF INITIAL PICTURE AND OUTCOME IN 108 PATIENTS, Blood, 88(10), 1996, pp. 898-898
Authors:
COIFFIER B
ANDERSON J
ARMITAGE J
BERGER F
CAVALLI F
CHAN W
CLOSE P
CONNORS J
DIEBOLD J
GASCOYNE R
HARRIS N
HIDDEMANN W
HO F
JACOBS P
LIANG R
LISTER A
MACCLENNAN K
MULLERHERMELINK H
NATHWANI B
NORTON A
OTT G
PEDRINIS E
ROSENBERG S
ROY P
SCHAUER A
WEISENBURGER D
Citation: B. Coiffier et al., CLINICAL PROGNOSTIC FACTORS ARE STRONGER PREDICTORS OF OUTCOME IN NON-HODGKINS-LYMPHOMA (NHL) THEN PATHOLOGICAL SUBTYPE, Blood, 88(10), 1996, pp. 1160-1160
Authors:
NEIDHARDTBERARD EM
GARCIA E
DURAND I
COIFFIER B
SALLES G
BANCHEREAU J
GARRONE P
Citation: Em. Neidhardtberard et al., RESISTANCE TO FAS-INDUCED APOPTOSIS IN CD40-ACTIVATED B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS, Blood, 88(10), 1996, pp. 1174-1174
Authors:
WARZOCHA K
RENARD N
CHARLOT C
BIENVENU J
COIFFIER B
SALLES G
Citation: K. Warzocha et al., LYMPHOTOXIN-ALPHA (LT-ALPHA) AND LYMPHOTOXIN-BETA (LT-BETA) GENES EXPRESSION IN TRANSFORMED-CELL LINES AND NON-HODGKINS-LYMPHOMAS - PRESENCE OF AN ALTERNATIVELY SPLICED FORM OF LT-BETA, Blood, 88(10), 1996, pp. 1497-1497
Authors:
WARZOCHA K
RENARD N
CHARLOT C
BIENVENU J
BASTION Y
NEIDHARTBERARD EM
DUMONTET C
COIFFIER B
SALLES G
Citation: K. Warzocha et al., THE TUMOR-NECROSIS-FACTOR, LYMPHOTOXIN AND FAS LIGAND-RECEPTOR SYSTEMGENES EXPRESSION IN NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 1498-1498
Authors:
SOLALCELIGNY P
LEPAGE E
BROUSSE N
TERTIAN G
THYSS A
REMAN O
SEBBAN C
PIGNON B
GISSELBRECHT C
COIFFIER B
COLE B
SUGANO D
TENDLER C
Citation: P. Solalceligny et al., A DOXORUBICIN CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B (IFN-ALPHA 2B) IN ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL, TOXICITY AND QUALITY-OF-LIFE OF THE GELF86 TRIAL, Blood, 88(10), 1996, pp. 1800-1800
Authors:
ARCHIMBAUD E
PHILIP I
COIFFIER B
MICHALLET M
SALLES G
SEBBAN C
ROUBI N
LOPEZ F
BESSUEILLE L
MAZARS P
JUTTNER C
ATKINSON K
PHILIP T
Citation: E. Archimbaud et al., CD34(-) PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR PATIENTS WITH MULTIPLE MYUELOMA()THY1(+)LIN(), Blood, 88(10), 1996, pp. 2370-2370
Authors:
HIDDEMANN W
BRITTINGER G
TIEMANN M
PARWARESCH R
STEIN H
LISTER AT
NORTON A
PITTALUGA S
DEWOLFPEETERS C
VANHOOF A
COIFFIER B
BERGER F
KLUINNELEMANNS H
VANKRIEKEN H
KLUIN P
CAVALLI F
ROGGERO E
PEDRINIS E
MONTSERRAT E
PIRIS MA
UNTERHALT M
Citation: W. Hiddemann et al., CLINICAL CHARACTERISTICS AND RESPONSE TO CHEMOTHERAPY OF MANTLE CELL LYMPHOMAS - RESULTS OF A EUROPEAN SURVEY, Blood, 88(10), 1996, pp. 2683-2683
Authors:
WILLIAMS CD
TAGHIPOUR G
LISTER TA
BLYSTAAD AM
COIFFIER B
GOLDSTONE AH
Citation: Cd. Williams et al., CHEMOSENSITIVE TRANSFORMED FOLLICULAR NON-HODGKINS-LYMPHOMA (NHL) IS A FIRM-INDICATION FOR HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION - A STUDY FROM THE EBMT REGISTRY, Blood, 88(10), 1996, pp. 2727-2727
Citation: B. Coiffier, SHOULD VINDESINE BE USED IN STANDARD CHEMOTHERAPY REGIMENS FOR LYMPHOMA, Journal of drug development and clinical practice, 7(3), 1995, pp. 151-158
Authors:
WARZOCHA K
BIENVENU J
COIFFIER B
SALLES G
Citation: K. Warzocha et al., MECHANISMS OF ACTION OF THE TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN LIGAND-RECEPTOR SYSTEM, European cytokine network, 6(2), 1995, pp. 83-96
Authors:
MARICHY C
DUMONTET C
BASTION Y
RIEUX C
BLAY JY
SALLES G
BIRON P
COIFFIER B
Citation: C. Marichy et al., HEPATIC ANGIOSARCOMA IN A PATIENT WITH ESSENTIAL THROMBOCYTHEMIA AND BUDD-CHIARI SYNDROME, European journal of cancer, 31A(3), 1995, pp. 423-423
Authors:
FERME C
BASTION Y
LEPAGE E
BERGER F
BRICE P
MOREL P
GABARRE J
NEDELLEC G
REMAN O
CHERON N
OBERLIN O
COIFFIER B
Citation: C. Ferme et al., THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE, Annals of oncology, 6(6), 1995, pp. 543-549
Citation: B. Coiffier, 14 YEARS OF HIGH-DOSE CHOP (ACVB REGIMEN) - PRELIMINARY CONCLUSIONS ABOUT THE TREATMENT OF AGGRESSIVE-LYMPHOMA PATIENTS, Annals of oncology, 6(3), 1995, pp. 211-217